14 studies found for:    ocrelizumab
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: ocrelizumab;   Drug: Rebif;   Drug: ocrelizumab placebo;   Drug: Rebif placebo
2 Active, not recruiting A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: ocrelizumab;   Drug: Rebif;   Drug: ocrelizumab placebo;   Drug: Rebif placebo
3 Completed A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: ocrelizumab
4 Terminated A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: ocrelizumab;   Drug: placebo
5 Active, not recruiting A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: placebo;   Drug: methotrexate;   Drug: ocrelizumabu 50mg;   Drug: ocrelizumabu 200mg;   Drug: ocrelizumab 500mg
6 Active, not recruiting A Study of Ocrelizumab in Patients With Primary Progressive Multiple Sclerosis
Condition: Multiple Sclerosis, Primary Progressive
Interventions: Drug: ocrelizumab;   Drug: Placebo;   Drug: methylprednisolone
7 Active, not recruiting A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: ocrelizumab;   Drug: placebo
8 Active, not recruiting A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
Condition: Rheumatoid Arthritis
Interventions: Drug: leflunomide;   Drug: methotrexate;   Drug: ocrelizumab;   Drug: placebo
9 Terminated A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: ocrelizumab;   Drug: placebo
10 Terminated A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: corticosteroids;   Drug: immunosuppressive regime;   Drug: methylprednisolone;   Drug: ocrelizumab;   Drug: placebo
11 Active, not recruiting A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: ocrelizumab;   Drug: placebo;   Drug: methylprednisolone;   Drug: interferon beta-1a
12 Active, not recruiting A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)
Conditions: Lupus Nephritis;   Systemic Lupus Erythematosus
Interventions: Drug: corticosteroids;   Drug: cyclophosphamide;   Drug: mycophenolate mofetil;   Drug: ocrelizumab;   Drug: placebo
13 Terminated A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab
Condition: Rheumatoid Arthritis
Interventions: Drug: infliximab;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: ocrelizumab;   Drug: sham
14 Recruiting Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)
Condition: Multiple Sclerosis
Intervention:

Indicates status has not been verified in more than two years